Our results show that CCL2 and CCR2 are expressed in prostate cancer cells, with CCL2 increased in the serum of prostate cancer patients, but the expression of both CCL2 and CCR2 exhibited no prognostic value. Here, CCL2 is linked to prostate carcinoma.